Cannabics Pharmaceuticals
Business Services · Maryland, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3 Bethesda Metro Ctr Ste 700, Bethesda, ...Phone Number
(877) 424-2429Website
www.cnbxpharma.comRevenue
<$5 MillionStock Symbol
CNBXIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Cannabics Pharmaceuticals
Cannabics Pharmaceuticals Inc. is a U.S. public company that is developing a platform that leverages novel drug-screening tools to create cannabinoid-based therapies for cancer that are more precise to a patient's profile. By developing tools to assess effectiveness on a personalized basis, Cannabics is helping to move cannabinoids into the future of cancer therapy. The Company's R&D is based in Israel, where it is licensed by the Ministry of Health to conduct scientific and clinical research on cannabinoid formulations and cancer. It was founded in 2004.Explore more
Cannabics Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cannabics Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Cannabics Pharmaceuticals is spiking on competitors!
Cannabics Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Cannabics Pharmaceuticals had a recent Job posting/layoffs
Product Launch: Get notified when Cannabics Pharmaceuticals launches new products
Earning: See what the market has to say on Cannabics Pharmaceuticals recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Cannabics Pharmaceuticals
Funding: Get notified immidiatlly once Cannabics Pharmaceuticals has new funding data
Check if Cannabics Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Cannabics Pharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to Cannabics Pharmaceuticals
Compare insights from companies similar to Cannabics Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cannabics Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cannabics Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cannabics Pharmaceuticals.
Cannabics Pharmaceuticals Tech Stack
A closer look at the technologies used by Cannabics Pharmaceuticals
Cannabics Pharmaceuticals News & Media
CNBX Selects API Supplier Purisys to Support Planned IND Fillings and Phase I/II (a) Clinical Trials
TEL AVIV, Israel and BETHESDA, Md., Nov. 4, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that it has signed an agreement with Purisys, a leading Active Pharmaceutical...Meet CNBX at Radiation Therapy Conference (RTC) 2021 in Chicago
TEL AVIV, Israel and BETHESDA, Md., Oct. 26, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that Company Scientific Advisory Board Member, Dr. Yonina Tova (MD), an...Radiation Oncology Expert Joins Cannabics Pharmaceuticals' Board of Advisors
TEL AVIV, Israel and BETHESDA, Md., Oct. 25, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that Dr. Yonina Tova (MD), internationally recognized Radiation Oncologist has...EDISON Publishes Healthcare QuickView on Cannabics Pharmaceuticals: CNBX
TEL AVIV, Israel and BETHESDA, Md., Oct. 21, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that EDISON Group issued a Healthcare QuickView publication on the company...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cannabics Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Cannabics Pharmaceuticals Inc. is a U.S. public company that is developing a platform that leverages novel drug-screening tools to create cannabinoid-based therapies for cancer that are more precise to a patient's profile. By developing tools to assess effectiveness on a personalized basis, Cannabics is helping to move cannabinoids into the future... Read More
